BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18202186)

  • 1. Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.
    Bianco C; Strizzi L; Mancino M; Watanabe K; Gonzales M; Hamada S; Raafat A; Sahlah L; Chang C; Sotgia F; Normanno N; Lisanti M; Salomon DS
    Am J Pathol; 2008 Feb; 172(2):345-57. PubMed ID: 18202186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo.
    Strizzi L; Bianco C; Raafat A; Abdallah W; Chang C; Raafat D; Hirota M; Hamada S; Sun Y; Normanno N; Callahan R; Hinck L; Salomon D
    J Cell Sci; 2005 Oct; 118(Pt 20):4633-43. PubMed ID: 16176936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Msx2 induces epithelial-mesenchymal transition in mouse mammary epithelial cells through upregulation of Cripto-1.
    di Bari MG; Ginsburg E; Plant J; Strizzi L; Salomon DS; Vonderhaar BK
    J Cell Physiol; 2009 Jun; 219(3):659-66. PubMed ID: 19170109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and localization of Cripto-1 binding in mouse mammary epithelial cells and in the mouse mammary gland using an immunoglobulin-cripto-1 fusion protein.
    Bianco C; Normanno N; De Luca A; Maiello MR; Wechselberger C; Sun Y; Khan N; Adkins H; Sanicola M; Vonderhaar B; Cohen B; Seno M; Salomon D
    J Cell Physiol; 2002 Jan; 190(1):74-82. PubMed ID: 11807813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice.
    Strizzi L; Bianco C; Normanno N; Seno M; Wechselberger C; Wallace-Jones B; Khan NI; Hirota M; Sun Y; Sanicola M; Salomon DS
    J Cell Physiol; 2004 Nov; 201(2):266-76. PubMed ID: 15334661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of a Nodal-independent signaling pathway by Cripto-1 mutants with impaired activation of a Nodal-dependent signaling pathway.
    Bianco C; Mysliwiec M; Watanabe K; Mancino M; Nagaoka T; Gonzales M; Salomon DS
    FEBS Lett; 2008 Dec; 582(29):3997-4002. PubMed ID: 19013461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia.
    Williams TM; Lee H; Cheung MW; Cohen AW; Razani B; Iyengar P; Scherer PE; Pestell RG; Lisanti MP
    J Biol Chem; 2004 Jun; 279(23):24745-56. PubMed ID: 15044451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
    Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS
    Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
    Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
    J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.
    Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA
    Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Netrin-1 can affect morphogenesis and differentiation of the mouse mammary gland.
    Strizzi L; Mancino M; Bianco C; Raafat A; Gonzales M; Booth BW; Watanabe K; Nagaoka T; Mack DL; Howard B; Callahan R; Smith GH; Salomon DS
    J Cell Physiol; 2008 Sep; 216(3):824-34. PubMed ID: 18425773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic ablation of caveolin-1 in mammary epithelial cells increases milk production and hyper-activates STAT5a signaling.
    Sotgia F; Schubert W; Pestell RG; Lisanti MP
    Cancer Biol Ther; 2006 Mar; 5(3):292-7. PubMed ID: 16418573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness.
    Sotgia F; Williams TM; Schubert W; Medina F; Minetti C; Pestell RG; Lisanti MP
    Am J Pathol; 2006 Jan; 168(1):292-309. PubMed ID: 16400031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade.
    Park DS; Lee H; Frank PG; Razani B; Nguyen AV; Parlow AF; Russell RG; Hulit J; Pestell RG; Lisanti MP
    Mol Biol Cell; 2002 Oct; 13(10):3416-30. PubMed ID: 12388746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells.
    Williams TM; Sotgia F; Lee H; Hassan G; Di Vizio D; Bonuccelli G; Capozza F; Mercier I; Rui H; Pestell RG; Lisanti MP
    Am J Pathol; 2006 Nov; 169(5):1784-801. PubMed ID: 17071600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia.
    Lee H; Park DS; Razani B; Russell RG; Pestell RG; Lisanti MP
    Am J Pathol; 2002 Oct; 161(4):1357-69. PubMed ID: 12368209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cripto-1 ablation disrupts alveolar development in the mouse mammary gland through a progesterone receptor-mediated pathway.
    Klauzinska M; McCurdy D; Rangel MC; Vaidyanath A; Castro NP; Shen MM; Gonzales M; Bertolette D; Bianco C; Callahan R; Salomon DS; Raafat A
    Am J Pathol; 2015 Nov; 185(11):2907-22. PubMed ID: 26429739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src.
    Bianco C; Strizzi L; Rehman A; Normanno N; Wechselberger C; Sun Y; Khan N; Hirota M; Adkins H; Williams K; Margolis RU; Sanicola M; Salomon DS
    Cancer Res; 2003 Mar; 63(6):1192-7. PubMed ID: 12649175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells.
    Wechselberger C; Ebert AD; Bianco C; Khan NI; Sun Y; Wallace-Jones B; Montesano R; Salomon DS
    Exp Cell Res; 2001 May; 266(1):95-105. PubMed ID: 11339828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells.
    Kannan S; De Santis M; Lohmeyer M; Riese DJ; Smith GH; Hynes N; Seno M; Brandt R; Bianco C; Persico G; Kenney N; Normanno N; Martinez-Lacaci I; Ciardiello F; Stern DF; Gullick WJ; Salomon DS
    J Biol Chem; 1997 Feb; 272(6):3330-5. PubMed ID: 9013573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.